Frances A Shepherd

Title: Frances A. Shepherd: Innovator in Lung Cancer Prognostics

Introduction

Frances A. Shepherd is a notable inventor based in Toronto, Canada, recognized for her significant contributions to the field of oncology, particularly in lung cancer research. With two patents to her name, she has advanced methodologies that improve the classification and treatment of lung cancer patients, aiming to enhance prognostic accuracy and therapeutic outcomes.

Latest Patents

Frances A. Shepherd's recent patents include a groundbreaking approach to lung cancer prognosis. The first patent, titled "Prognostic and Predictive Gene Signature for Non-Small Cell Lung Cancer and Adjuvant Chemotherapy," offers innovative methods to classify lung cancer patients into poor and good survival groups. This invention also evaluates the benefits of adjuvant chemotherapy through a multigene signature and provides kits and computer products to assist in these methods. The second patent, "Materials and Methods for Prognosing Lung Cancer Survival," further enhances prognostic capabilities by classifying lung cancer patients into survival groups, with additional kits designed for practical application.

Career Highlights

Frances A. Shepherd is affiliated with the University Health Network, a leading healthcare and research institution. Her career is marked by dedicated research efforts aimed at enhancing patient outcomes in lung cancer treatment. Through her pioneering work, she strives to revolutionize traditional cancer prognostication and personalize treatment plans, significantly impacting the field of oncology.

Collaborations

Throughout her career, Frances has collaborated with esteemed colleagues, including Igor Jurisica and Sandy D. Der. These partnerships have driven interdisciplinary approaches to oncology, fostering innovation and expanding the horizons of cancer research.

Conclusion

Frances A. Shepherd exemplifies how dedicated inventors can influence the medical field through innovation. Her patents reflect not only her expertise but also her commitment to improving the lives of lung cancer patients. By integrating advanced genetic insights with practical methodologies, Frances continues to contribute significantly to the fight against cancer, leaving a lasting impact on the medical community.